Market By Products, Applications, End-users And Geography | Forecast 2019-2027
The global immunohistochemistry market is expected to display an upward trend in terms of revenue by exhibiting a CAGR of 7.11% over the forecast period of 2019-2027. The market was assessed to be worth $1727 million in the year 2018 and is predicted to generate a revenue of approximately $3225 million by the year 2027.
Immunohistochemistry (IHC) is the process that involves selectively imaging antigens (proteins) in the cells of a tissue section by the exploitation of the principle of antibodies that bind particularly to antigens in biological tissues. IHC derives its name from the word "immuno," that refers to antibodies used in the procedure. The term "histo" stands for tissue.
Report scope can be customized per your requirements. Request For Customization
Immunohistochemical staining is extensively used for diagnosing abnormal cells like those found in cancerous tumors. Specific molecular markers are a characteristic attribute of specific cellular events like the proliferation or cell death (apoptosis). IHC is also used extensively in general research to understand the localization and distribution of biomarkers and differential expression proteins in various parts of biological tissue.
Traditionally, immunodetectors use the 3 step biotin-streptavidin-enzyme technique. However, novel technological enhancements have helped to develop the polydetectors and cytodetectors kits that implement tandem hyperlabelling technology to directly label immunoglobulins with enzymes, thus resulting in reproducible and consistent immunostaining for all types of nuclear, cytoplasmic and membranal antigens in various types of cells or tissues.
In 2016, North America accounted for the highest revenue share in the global market, mainly due to factors such as the rising incidences of chronic diseases, matured biotechnology industry, the rising commercialization of the immunohistochemistry products and developed research & healthcare institutions. Within this report, the history of immunochemistry and key insights regarding the industry have been discussed in detail. Also, the market attractiveness matrix, regulatory outlook and the value chain outlook have been studied for the immunohistochemistry industry.
Market drivers like the in-vitro technological advancements, an increase in the cancer cases, the increasing healthcare spending, the rise in the geriatric population and the growing use of POC testing have been thoroughly analyzed. The industry is facing restraints like restriction of systems and reimbursement issues which are obstructing the industry growth. Key opportunities like the increasing use of biomarkers for disease diagnosis and technological advancements can be leveraged by the industry to get towards the projected growth.
Challenges such as the stringent regulations and high maintenance costs which are influencing the market growth are being faced by this industry presently.
To get detailed insights on segments, Download Sample Report
Geographies covered in the global immunohistochemistry market:
• North America: the United States and Canada
• Europe: the United Kingdom, Germany, France, Italy, Spain, Russia and rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and rest of Asia-Pacific
• Latin America: Brazil, Mexico, Argentina, Chile, Cuba and rest of Latin America
• The Middle East & Africa: the United Arab Emirates, Turkey, Saudi Arabia, South Africa and rest of the Middle East & Africa
The immunohistochemistry market has been segmented into:
• By products:
o Antibodies
• Primary antibodies
• Secondary antibodies
o Equipment
• Slide staining systems
• Tissue microarrays
• Tissue processing systems
• Slide scanners
• Other equipment
o Reagents
• Histological stains
• Blocking sera and reagents
• Chromogenic substrates
• Fixation reagents
• Stabilizers
• Organic Solvents
• Proteolytic Enzymes
• Diluents
o Kits
• By applications:
o Diagnostics
• Cancer
• Infectious disease
• Cardiovascular disease
• Autoimmune diseases
• Diabetes mellitus
• Nephrological diseases
o Drug testing
• By end-users:
o Hospitals and diagnostic laboratories
o Research institutes
o Other end-users
The key players in the immunohistochemistry market include Cell Signaling Technology, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., HistologiX, BioGenex, Bio SB, Abcam Plc, PerkinElmer, Inc., Danaher Corporation, Siemens AG Healthcare, Agilent Technologies, Inc., F. Hoffmann-La Roche AG and Abbott Laboratories.
The strategic analysis for each of these companies in the immunohistochemistry market has been covered in detail. The players in this industry are undergoing mergers & acquisitions to address the increasing pace and level of competition worldwide. The company market share helps to dive into the information about the key market players in this industry and how much hold they have on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. IMMUNOHISTOCHEMISTRY
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. HISTORY
OF IMMUNOHISTOCHEMISTRY
2.3. VALUE
CHAIN OUTLOOK
2.4. KEY
INSIGHTS
2.5. REGULATORY
OUTLOOK
2.5.1. REGULATIONS
IN THE UNITED STATES
2.6. MARKET
ATTRACTIVENESS MATRIX
2.7. MARKET
DRIVERS
2.7.1. IN-VITRO
TECHNOLOGICAL ADVANCEMENTS
2.7.2. INCREASING
CANCER OCCURRENCE
2.7.3. SWELLING
HEALTHCARE SPENDING
2.7.4. RISING
GERIATRIC POPULATION
2.7.5. INCREASING
USE OF POC TESTING
2.8. MARKET
RESTRAINTS
2.8.1. RESTRICTIONS
OF CLOSED SYSTEMS
2.8.2. REIMBURSEMENT
ISSUES
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
USE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.9.2. TECHNOLOGICAL
ADVANCEMENTS
2.10.
MARKET CHALLENGES
2.10.1.
STRINGENT REGULATIONS
2.10.2.
HIGH MAINTENANCE COST
INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY
ANTIBODIES
3.1.2. SECONDARY
ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE
STAINING SYSTEMS
3.2.2. TISSUE
MICROARRAYS
3.2.3. TISSUE
PROCESSING SYSTEMS
3.2.4. SLIDE
SCANNERS
3.2.5. OTHER
EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL
STAINS
3.3.2. BLOCKING
SERA AND REAGENTS
3.3.3. CHROMOGENIC
SUBSTRATES
3.3.4. FIXATION
REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC
SOLVENTS
3.3.7. PROTEOLYTIC
ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS
DISEASES
4.1.3. CARDIOVASCULAR
DISEASE
4.1.4. AUTOIMMUNE
DISEASES
4.1.5. DIABETES
MELLITUS
4.1.6. NEPHROLOGICAL
DISEASES
4.2. DRUG
TESTING
5. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS
AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH
INSTITUTES
5.3. OTHER
END-USERS
6. IMMUNOHISTOCHEMISTRY
(IHC) MARKET - REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY PRODUCTS
6.1.2. MARKET
BY APPLICATIONS
6.1.3. MARKET
BY END-USERS
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. THE
UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY PRODUCTS
6.2.2. MARKET
BY APPLICATIONS
6.2.3. MARKET
BY END-USERS
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. THE
UNITED KINGDOM
6.2.4.2. FRANCE
6.2.4.3. GERMANY
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. RUSSIA
6.2.4.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY PRODUCTS
6.3.2. MARKET
BY APPLICATIONS
6.3.3. MARKET
BY END-USERS
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. INDIA
6.3.4.3. JAPAN
6.3.4.4. SOUTH
KOREA
6.3.4.5. AUSTRALIA
& NEW ZEALAND
6.3.4.6. ASEAN
COUNTRIES
6.3.4.7. REST
OF APAC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY PRODUCTS
6.4.2. MARKET
BY APPLICATIONS
6.4.3. MARKET
BY END-USERS
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. ARGENTINA
6.4.4.4. CHILE
6.4.4.5. CUBA
6.4.4.6. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY PRODUCTS
6.5.2. MARKET
BY APPLICATIONS
6.5.3. MARKET
BY END-USERS
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. SAUDI
ARABIA
6.5.4.2. TURKEY
6.5.4.3. UNITED
ARAB EMIRATES
6.5.4.4. SOUTH
AFRICA
6.5.4.5. REST
OF MIDDLE EAST AND AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. ABCAM
PLC
7.3. AGILENT
TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD
LABORATORIES, INC.
7.6. BIO
SB
7.7. CELL
SIGNALING TECHNOLOGY, INC.
7.8. DANAHER
CORPORATION
7.9. F.
HOFFMANN-LA ROCHE AG
7.10.
HISTOLOGIX
7.11.
MERCK MILLIPORE
7.12.
PERKINELMER, INC.
7.13.
SIEMENS AG HEALTHCARE
7.14.
THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY
AND SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1 GLOBAL MARKET FOR IMMUNOHISTOCHEMISTRY BY
REGION 2019-2027 ($ MILLION)
TABLE 2 ANTIBODY MANUFACTURERS IN THE GLOBAL
IMMUNOHISTOCHEMISTRY MARKET
TABLE 3 CANCER MARKERS USED IN DIAGNOSIS AND
TREATMENT
TABLE 4 POPULATION AGED 60 YEARS AND ABOVE
TABLE 5 POPULATION AGED 80 YEARS AND ABOVE
TABLE 6 COUNTRIES WITH THE HIGHEST NUMBER OF
ELDERLY PEOPLE
TABLE 7 GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY
PRODUCTS 2019-2027 ($ MILLION)
TABLE 8 INCIDENCE OF DIABETES IN MAJOR COUNTRIES
2016 ($ MILLION)
TABLE 9 CLINICALLY IMPORTANT MONOCLONAL
ANTIBODIES
TABLE 10 SECONDARY ANTIBODY SELECTION
TABLE 11 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN
EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 12 HEALTHCARE SPENDING BY HIGH-INCOME
COUNTRIES BY 2040
TABLE 13 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN
REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 14 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 15 COMMON FIXATIVES AND THEIR GENERAL TARGET
ANTIGENS
TABLE 16 KIT COMPONENTS ARE AVAILABLE FOR IHC
OPTIMIZATION
TABLE 17 GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY
APPLICATION 2019-2027 ($ MILLION)
TABLE 18 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS
BY TYPE 2019-2027 ($ MILLION)
TABLE 19 SELECTED INFECTIOUS ETIOLOGIES OF
AUTOIMMUNE DISEASES
TABLE 20 GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY
END-USERS 2019-2027 ($ MILLION)
TABLE 21 CANCER RESEARCH PROGRAM
TABLE 22 IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC
PATHOLOGY
TABLE 23 GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY
REGION 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 25 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 26 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY END-USERS 2019-2027 ($ MILLION)
TABLE 27 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY COUNTRY 2019-2027 ($ MILLION)
TABLE 28 FUNDS INVESTED FOR DIFFERENT CANCER TYPES
(2017)
TABLE 29 PERCENT DISTRIBUTION OF PROJECTED NEW
CANCER CASES (2017)
TABLE 30 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY
PRODUCTS 2019-2027 ($ MILLION)
TABLE 31 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY
APPLICATIONS 2019-2027 ($ MILLION)
TABLE 32 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY
END-USERS 2019-2027 ($ MILLION)
TABLE 33 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY
COUNTRY 2019-2027 ($ MILLION)
TABLE 34 NUMBER OF PEOPLE LIVING AND DYING WITH
CVD
TABLE 35 NUMBER OF DEATHS CAUSED BY CARDIOVASCULAR
DISEASES IN GERMANY 2016
TABLE 36 DISEASES CAUSING PREMATURE DEATH IN
GERMANY (2017)
TABLE 37 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 38 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 39 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
BY END-USERS 2019-2027 ($ MILLION)
TABLE 40 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
BY COUNTRY 2019-2027 ($ MILLION)
TABLE 41 CANCER TYPES BASED ON INCIDENCE RATES
(2016)
TABLE 42 CANCER TYPES BASED ON MORTALITY RATES
(2016)
TABLE 43 ESTIMATED INCIDENCE OF ALL CANCERS
COMBINED BY SEX (2017)
TABLE 44 ESTIMATED COMMON CAUSES OF DEATH FOR
CANCER (MALES 2017)
TABLE 45 ESTIMATED COMMON CAUSES OF DEATH FOR
CANCER (FEMALES 2017)
TABLE 46 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
TABLE 47 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 48 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 49 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY END-USERS 2019-2027 ($ MILLION)
TABLE 50 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY COUNTRY 2019-2027 ($ MILLION)
TABLE 51 CAUSES OF DEATH IN ARGENTINA 2016
TABLE 52 CAUSES OF DEATH IN CUBA 2016
TABLE 53 MIDDLE EAST AND AFRICA
IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 54 MIDDLE EAST AND AFRICA
IMMUNOHISTOCHEMISTRY MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 55 MIDDLE EAST AND AFRICA
IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)
TABLE 56 MIDDLE EAST AND AFRICA
IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 GLOBAL MARKET FOR IMMUNOHISTOCHEMISTRY
2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN
ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 GLOBAL ANTIBODIES MARKET IN PRIMARY
ANTIBODIES BY REGION 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL ANTIBODIES MARKET IN SECONDARY
ANTIBODIES REGION 2019-2027 ($ MILLION)
FIGURE 6 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN
EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL EQUIPMENT MARKET IN SLIDE STAINING
SYSTEMS BY REGION 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL EQUIPMENT MARKET IN TISSUE
MICROARRAYS BY REGION 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL EQUIPMENT MARKET IN TISSUE
PROCESSING SYSTEMS BY REGION 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL EQUIPMENT MARKET IN SLIDE SCANNERS BY
REGION 2019-2027 ($ MILLION)
FIGURE 11 GLOBAL EQUIPMENT MARKET IN OTHER EQUIPMENT BY
REGION 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN
REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL REAGENTS MARKET IN HISTOLOGICAL STAINS
BY REGION 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL REAGENTS MARKET IN BLOCKING SERA AND
REAGENTS BY REGION 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL REAGENTS MARKET IN CHROMOGENIC
SUBSTRATES BY REGION 2019-2027 ($ MILLION)
FIGURE 16 GLOBAL REAGENTS MARKET IN FIXATION REAGENTS
BY REGION 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL REAGENTS MARKET IN STABILIZERS BY
REGION 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL REAGENTS MARKET IN ORGANIC SOLVENTS BY
REGION 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL REAGENTS MARKET IN PROTEOLYTIC ENZYMES
BY REGION 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL REAGENTS MARKET IN DILUENTS BY REGION
2019-2027 ($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN KITS
2019-2027 ($ MILLION)
FIGURE 23 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS
2019-2027 ($ MILLION)
FIGURE 24 GLOBAL DIAGNOSTICS MARKET IN CANCER BY REGION
2019-2027 ($ MILLION)
FIGURE 25 DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE
BY REGION 2019-2027 ($ MILLION)
FIGURE 26 GLOBAL DIAGNOSTICS MARKET IN AUTOIMMUNE
DISEASES BY REGION 2019-2027 ($ MILLION)
FIGURE 27 GLOBAL DIAGNOSTICS MARKET IN DIABETES
MELLITUS BY REGION 2019-2027 ($ MILLION)
FIGURE 28 GLOBAL DIAGNOSTICS MARKET IN NEPHROLOGICAL
DISEASES BY REGION 2019-2027 ($ MILLION)
FIGURE 29 HEALTHCARE EXPENDITURES ACROSS THE GLOBE (%
OF GDP)
FIGURE 30 GLOBAL PREVALENCE OF CHRONIC KIDNEY DISEASES
BY AGE
FIGURE 31 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DRUG
TESTING 2019-2027 ($ MILLION)
FIGURE 32 INCIDENCE OF PATIENTS WITH CHRONIC DISEASES
GLOBALLY 2005-2030
FIGURE 33 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN
HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 34 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN
RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 35 GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN OTHER
END-USERS 2019-2027 ($ MILLION)
FIGURE 36 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 37 THE UNITED STATES IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 38 CANADA IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 39 EUROPE IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 40 THE UNITED KINGDOM IMMUNOHISTOCHEMISTRY
MARKET 2019-2027 ($ MILLION)
FIGURE 41 FRANCE IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 42 GERMANY IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 43 SPAIN IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 44 ITALY IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 45 RUSSIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 46 REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 47 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 48 CHINA IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 49 INDIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 50 JAPAN IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 51 SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 52 AUSTRALIA & NEW ZEALAND
IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 53 ASEAN COUNTRIES IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 54 REST OF APAC IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 55 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 56 BRAZIL IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 57 HEALTHCARE SPENDING IN MEXICO 2014 AND 2040 ($
BILLION)
FIGURE 58 MEXICO IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 59 HEALTHCARE SPENDING IN ARGENTINA 2014 AND
2040 ($ BILLION
FIGURE 60 ARGENTINA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 61 CHILE IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 62 HEALTHCARE EXPENDITURE IN CHILE 2005-2016
(PERCENTAGE SHARE OF GDP)
FIGURE 63 HEALTHCARE SPENDING IN CUBA (2014 AND 2040)
FIGURE 64 CUBA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($
MILLION)
FIGURE 65 REST OF LATIN AMERICA IMMUNOHISTOCHEMISTRY
MARKET 2019-2027 ($ MILLION)
FIGURE 66 MIDDLE EAST AND NORTH AFRICA
IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 67 SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 68 TURKEY IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 69 UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY
MARKET 2019-2027 ($ MILLION)
FIGURE 70 SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 71 REST OF MIDDLE EAST AND AFRICA
IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)